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AbstrACt 
Objectives This study aimed to examine the impact of the 
‘ICAN QUIT in Pregnancy’ intervention on individual health 
providers (HPs) smoking cessation care (SCC) knowledge, 
attitudes and practices in general, and specifically 
regarding nicotine replacement therapy (NRT) prescription.
Design Step-wedge clustered randomised controlled 
study. HPs answered a preintervention and 1–6 months 
postintervention survey.
setting Six Aboriginal Medical Services (AMSs) in three 
states of Australia.
Participants All HPs were invited to participate. Of 93 
eligible, 50 consented (54%), 45 completed the presurvey 
(90%) and 20 the post (40%).
Intervention Included three 1-hour webinar sessions, 
educational resource package and free oral NRT.
Outcomes HPs knowledge was measured using 
two composite scores—one from all 24 true/false 
statements, and one from 12 NRT-specific statements. 
Self-assessment of 22 attitudes to providing SCC were 
measured using a five-point Likert scale (Strongly disagree 
to Strongly agree). Two composite mean scores were 
calculated—one for 15 general SCC attitudes, and one for 
7 NRT-specific attitudes. Self-reported provision of SCC 
components was measured on a five-point Likert scale 
(Never to Always). Feasibility outcomes, and data collected 
on the service and patient level are reported elsewhere.
results Mean knowledge composite scores improved 
from pre to post (78% vs 84% correct, difference 5.95, 
95% CI 1.57 to 10.32). Mean NRT-specific knowledge 
composite score also improved (68% vs 79% correct, 
difference 9.9, 95% CI 3.66 to 16.14). Mean attitude 
composite score improved (3.65 (SD 0.4) to 3.87 (SD 0.4), 
difference 0.23, 95% CI 0.05 to 0.41). Mean NRT-specific 
attitudes composite score also improved (3.37 (SD 0.6) to 
3.64 (SD 0.7), difference 0.36, 95% CI 0.13 to 0.6). Self-
reported practices were unchanged, including prescribing 
NRT.
Conclusions A multicomponent culturally sensitive 
intervention in AMSs was feasible, and might improve HPs 
provision of SCC to pregnant Aboriginal women. Changes 
in NRT prescription rates may require additional intensive 
measures.
trial registration number ACTRN 12616001603404; 
Results.
IntrODuCtIOn
Smoking during pregnancy remains a serious 
public health problem. Global rates range 
from 0.2% to 38%, with higher rates of 
30%–50%, across high-priority subpopula-
tions.1 2 In Australia, 10% of pregnant women 
smoke, with the highest rates across socially 
disadvantaged subpopulations, such as 
Aboriginal and Torres Strait Islander women 
(44%) (hereafter referred to as ‘Aborig-
inal’ women with acknowledgement of the 
distinct cultures).3 The Aboriginal popula-
tion compromise 3% of the total Australian 
population,4 but due to historical, cultural 
and social reasons, have the highest smoking 
prevalence (42%).5 6 Tobacco was introduced 
to Aboriginal people through trade with 
Indonesian fisherman and quickly became 
embedded in the social and ceremonial 
life.7 Colonisation had a huge impact on 
smoking rates as tobacco was often used by 
strengths and limitations of this study
 ► The first study in Australia that specifically targeted 
health providers’ (HPs) care for pregnant Aboriginal 
and Torres Strait Islander women who smoke.
 ► The first intervention that had a major focus on 
improving prescription rates of nicotine replace-
ment therapy to support smoking cessation during 
pregnancy.
 ► The intervention, including the novel use of live in-
teractive webinar training, was informed by theory 
and based on a solid foundation of prior formative 
research.
 ► This study was a pilot aimed to assess feasibility, 
and was not powered to assess the effectiveness of 
the intervention.
 ► This study included HPs who work at Aboriginal 
Medical Services only, and may not be generalised 
to other antenatal care settings that Aboriginal and 
Torres Strait Islander women might attend.
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European settlers as an accepted method of payment to 
Aboriginal people.8 
Reducing smoking prevalence during pregnancy can 
lead to significant positive impacts on long-term devel-
opment of Aboriginal babies and help to reduce the 
health gap between the Non-Aboriginal and the Aborig-
inal population.9 Reducing tobacco use is considered 
to be one of the key areas for intervention to improve 
infant and maternal health outcomes, under the 2018 
‘Closing the Gap’ governmental strategy for Aboriginal 
Australians.10
Pregnant Aboriginal women face many barriers to quit-
ting smoking,11–13 including multiple and intercurrent life 
stressors, and living in communities with high smoking 
rates. A significant barrier, commonly cited, is the lack 
of adequate support from health providers (HPs), with 
inconsistent health messages often provided.13–15
Effective interventions to increase rates of smoking 
cessation during pregnancy include behavioural coun-
selling, incentives and feedback (ie, when the pregnant 
woman is offered an objective measurement of the effects 
of tobacco smoking, such as the level of carbon monoxide 
in expired air).1
The most recent Cochrane review on using pharmaco-
therapy to aid smoking cessation in pregnancy concluded 
that nicotine replacement therapy (NRT) increased 
cessation rates by 40%.16 On  average, quit rates increased 
from 9.2% with placebo to 12.2% with NRT.16 However, 
excluding non-placebo controlled studies resulted 
in non-significant changes. Therefore, the evidence 
regarding the use of NRT in pregnancy is still not robust. 
Furthermore, adherence to NRT was identified as a 
problem.16
Australian smoking cessation guidelines recommend 
the use of NRT if a pregnant woman has not been able to 
quit smoking with counselling alone.17 Despite this, 25% 
of Australian general practitioners and obstetricians have 
reported they would ‘never’ prescribe NRT during preg-
nancy, with 55% reporting safety concerns about NRT use 
in pregnancy.18 A recent systematic review identified that 
HPs are not providing pregnant women adequate support 
to quit, specifically in regard to behavioural counselling, 
referral to specialist support (such as the Quitline) and 
prescription of NRT.19 Several reviews have outlined 
numerous barriers HPs face to providing smoking cessa-
tion care (SCC) during pregnancy, including lack of 
knowledge and skills, low confidence in ability to counsel, 
low optimism regarding the effectiveness of treatment, 
and lack of time and resources.20 21 The same barriers 
were echoed recently in two Australian studies including 
HPs treating Aboriginal pregnant mothers.22 23
To date, there have been two published studies focusing 
on smoking cessation in Australian Aboriginal pregnant 
women,24 25 neither focused on the HPs provision of care, 
or on the use of NRT during pregnancy. Both imple-
mented face-to-face smoking cessation training of HPs as 
part of the intervention. Despite an increase in webinar 
use as a mechanism for training HPs, very few studies have 
tested its effectiveness in regard to smoking cessation 
training.26 27 A recent systematic review on interventions 
to improve HPs provision of SCC during pregnancy iden-
tified 14 different interventions, none of which included 
webinar training, and none included components aimed 
specifically at improving NRT prescription.28
The Indigenous Counselling and Nicotine (ICAN) 
QUIT in Pregnancy trial29 was a pilot study with an overall 
aim of testing the feasibility and acceptability of a multi-
component smoking cessation training intervention for 
HPs in Aboriginal Medical Services (AMSs). The interven-
tion included 3 hours of live interactive webinar training, 
an educational resource package and free oral NRT.29 
The intervention was developed collaboratively with two 
AMSs and a Stakeholder and Consumer Aboriginal Advi-
sory Panel guiding the development and implementa-
tion of the intervention to ensure Aboriginal community 
ownership and cultural sensitivity. A full description of the 
development of this intervention is provided elsewhere.30
The results of this pilot study will inform the develop-
ment and design of a larger cluster randomised controlled 
trial (SISTAQUIT—Supporting Indigenous Smokers To 
Assist Quitting).
This study examined the impact of ‘ICAN QUIT in 
Pregnancy’ on HPs’ knowledge, attitudes and practices 
regarding SCC during pregnancy in general, and specif-
ically on recommending NRT during pregnancy. The 
usefulness of the educational resources was also assessed.
MethODs
Design
The ‘ICAN QUIT in Pregnancy’ study was a step-wedge 
clustered randomised trial (figure 1). Full details of 
the study can be found in the protocol manuscript 
(online supplementary file 1).29 In short, six AMSs 
were randomised into three clusters, with the interven-
tion sequentially delivered to each cluster 2 months 
following study commencement, staggered by 1 month. 
The trial included data collection at the service and HPs 
levels, and from pregnant participants with the primary 
outcomes focused on feasibility.29 In this manuscript, we 
report on the HPs secondary outcome data. The feasi-
bility outcomes, service level and women’s level data are 
reported elsewhere31 (Bovill et al, Wingadhan Birrang 
(woman’s journey) of smoking cessation during preg-
nancy: Aboriginal and Torres Strait Islander women 
participating in the Indigenous Counselling and Nicotine 
(ICAN) QUIT in Pregnancy pilot study). All HPs in each 
service were invited to receive the training, and complete 
a survey pretraining and post-training (figure 1). Origi-
nally, HPs were to complete two postsurveys—at 1 and 
6 months post-training. Few HPs completed the post-
survey 1-month post-training, and multiple reminders to 
complete the postsurvey were required over the follow-up 
period. Therefore, only one postsurvey was collected 
from each HP (between 1 and 6 months post-training).
P
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setting
Six AMSs—one urban and five regional—in three states 
of Australia—New South Wales, Queensland and South 
Australia. The AMSs were all Aboriginal Community 
Controlled Health Services, which are non-government 
organisations operated by local Aboriginal and Torres 
Strait Islander communities, to deliver holistic, compre-
hensive and culturally appropriate healthcare to the 
communities that govern them through an elected board 
of management.32
Participants
All of the HPs from each service were invited to partic-
ipate, as long as they consulted with pregnant women 
either for confirmation of pregnancy, antenatal care 
and/or routine care. These included general practi-
tioners, midwives, Aboriginal Health Workers and other 
allied HPs. Aboriginal Health Workers are Aboriginal 
people who have undertaken specific training to work 
within primary care, either in non-clinical liaison or clin-
ical roles.33 Managers were also welcomed to attend the 
training as non-participants.
randomisation
Randomisation occurred at the service level only, with 
allocation of the AMSs to the clusters based on geograph-
ical convenience. For each cluster, the period of treatment 
crossover was randomised using simple randomisation. 
Due to the step-wedge cluster design, HPs from each 
service received the training, and completed the surveys 
at different time points in the study, staggered by 1 month 
between each cluster (figure 1).
Intervention
Intervention included (a) three 1-hour sessions of live 
interactive webinar training for HPs, (b) an educational 
resource package for both HPs and pregnant women and 
(c) free oral forms of NRT to be dispensed to women 
on-site.29 34
a. Webinar training was chosen to accommodate time 
and location constraints, important for future poten-
tial scaling of the intervention to other regional and 
remote AMSs. Webinars included PowerPoint pre-
sentations, embedded short videos and group discus-
sions.34 A full description of the webinar content can 
be found in online supplementary file 2. The webi-
nars were recorded and supplied to each service. This 
enabled training for those HPs that could not attend 
the live webinar, and allowed HPs to view the webinar 
again if needed. Originally, the webinars were planned 
to be weekly, over 3 weeks, but all the services request-
ed them to be in one 3-hour time slot, due to HPs time 
limits.
b. The educational resource package included resourc-
es specifically for the HPs (a treatment manual, and a 
mousepad depicting the NRT treatment algorithm to 
act as a prompt), resources specifically for the wom-
en (patient booklet, posters showing different NRT 
options and the differences in chemical content be-
tween NRT and a cigarette) and resources for a joint 
discussion (a flipchart). Development and assessment 
of these resources, and full details regarding the inter-
vention can be found elsewhere.29 34 35 The educational 
resource package was provided to the services both in 
hard copies (one for each HP) and in a digital copy.
c. All forms of oral NRT were supplied to the services 
(gum, lozenge, spray and inhalator) to be provided as 
needed free of charge to the women. Originally, oral 
NRT was to be supplied through a pharmacy voucher 
system, but all of the services requested that it would 
be dispensed directly at the service, to accommodate 
time and travel constraints for their patients. Due to 
the higher metabolism in pregnancy,36 it was advised to 
initiate treatment with the higher oral NRT dose (such 
as the 4 mg gum or lozenge). Services were supplied 
with sample packs for each woman, and supplies to last 
for a 3 months treatment period. NRT patches were 
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available for free under the Australian Government 
Pharmaceutical Benefits Scheme (PBS).37 In Australia, 
NRT can be bought without a prescription at pharma-
cies, but in order to qualify for the PBS subsidisation, a 
script from a medical doctor is required.37
The original plan was to include audit and feedback 
through a collection of monthly de-identified computer-
ised data from each service regarding NRT prescription 
rates to pregnant women, providing each service with a 
monthly report on their prescription rates, compared 
with the other services in the study.29 Unfortunately, 
audit and feedback was not feasible as services took a few 
months to organise the computerised data, and only four 
services were able to provide the data regarding NRT 
prescriptions to pregnant women.31
The HPs training followed the ABCD approach for 
brief behavioural counselling for Aboriginal pregnant 
women (Ask about smoking; Brief advice to quit; provide 
Cessation support and Discuss the psychosocial context 
of smoking), together with an expedited offer of NRT 
if a woman is unable to quit without medication.38 The 
training included specific guidance and resources 
focusing on improving knowledge and skills for recom-
mending NRT during pregnancy.29 34 35
Development of the intervention was based on forma-
tive research,13 18 22 39–42 and extensive consultation with 
Aboriginal stakeholders and communities.30 35 Develop-
ment was also informed by a rigorous theoretical analysis,34 
based on the Behaviour Change Wheel43 and the linked 
Theoretical Domains Framework (TDF).44 The Behaviour 
Change Wheel is a parsimonious model developed from 
an overarching synthesis of behaviour intervention frame-
works.43 The TDF is a validated and integrative theoretical 
framework developed for behaviour change research and 
cross-disciplinary implementation.44 45 The TDF covers a 
range of domains known to be relevant to professional 
behaviour change and has been applied across a wide 
range of clinical situations.45 Both the Behaviour Change 
Wheel and the TDF are used to practically identify and 
remediate barriers to achieving evidence-based care.
survey
A 102-item self-administered online or hard copy survey. 
Complete description of the survey measures can be 
found in online supplementary file 1.29
The items reported in this paper are defined as follows:
SCC knowledge
SCC knowledge was measured with a total composite 
score of 24 true/false statements. Of these, 12 statements 
were related to NRT use in pregnancy, so two additional 
separate knowledge composite scores were calculated—
one specific to NRT (12 statements) and one general 
knowledge composite score (12 statements).
Attitudes to providing SCC
Attitudes to providing SCC were measured using five-
point Likert scales (Strongly disagree (1) to Strongly 
agree (5); or Not often (1) to Very often (5)) for 15 state-
ments covering 13 domains from the TDF45 (knowledge, 
reinforcement, role/identity, beliefs about capabilities, 
optimism, beliefs about consequences, social influence/
subjective norm, goals/priority, memory/attention, envi-
ronmental context and resources, emotions/stress, inten-
tions and behavioural regulation). The Likert scales were 
dichotomised to ‘Agree/Strongly agree’ versus rest; or 
‘Not often (1)/(2) versus rest. A mean composite score 
was created for all of the TDF domains. Seven domains 
from the TDF included an additional separate question 
regarding the prescription or recommendation of NRT 
(knowledge, role/identity, beliefs about capabilities, opti-
mism, intentions, goals/priority and memory/attention); 
measured and dichotomised as above. A mean composite 
score for all NRT-specific TDF statements was also created.
In addition, self-reported perceptions of using NRT in 
pregnancy were measured, rating the safety for the fetus 
(dichotomised to ‘Very safe/Always safer than smoking’ 
vs else), effectiveness in NRT as an aid to pregnant 
smokers to quit (dichotomised to ‘Very/Moderately effec-
tive vs ‘Low’ effectiveness) and perceived adherence of 
pregnant smokers’ use of NRT (dichotomised to ‘Most 
adhere well’ vs Equal numbers adhere well and poorly/
Few adhere well).
Provision of SCC
Provision of SCC was measured using five-point Likert 
scales (Never to Always) on 12 different SCC compo-
nents (online supplementary file 1). The Likert scales 
were dichotomised into ‘Often/Always’ versus rest. NRT 
prescription was also measured in proportion reporting 
‘Never’ prescribing NRT (dichotomised to ‘Never’ vs 
else). HPs assessment of exposure to other substances 
that include nicotine (such as electronic cigarette or 
secondhand smoke, see online supplementary file 1) was 
measured and dichotomised as above.
Usefulness of educational resources
Usefulness of educational resources was measured using 
five-point Likert scales (Not useful at all to Very useful) for 
each webinar session and for each educational resource.
sample size
Sample size calculations for this study were guided by the 
primary outcome of pregnant women’s recruitment rate,29 
assuming that for each service the expected recruitment 
would be 10 eligible consenting women. This resulted 
in six services participating, with an expected 5–10 HPs 
eligible at each service (total 30–60 HPs).29
Analysis
Demographic and patient or practice information 
is presented as means (SD) or counts (%). Changes 
between the time points were examined using mixed 
modelling to account for repeated measures on some 
of the HPs; a fixed effect for time period was included, 
and a random effect for HP and service were modelled. A 
random intercept for the cluster was not modelled due to 
P
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the low number of clusters (three). Outcomes with Likert 
scale answers were originally modelled using ordinal 
logistic mixed modelling; however, due to low numbers, 
none of the models converged. Therefore, responses were 
dichotomised and logistic mixed modelling was used. 
Results are presented for each response, and the OR for 
the dichotomised outcome (with 95% CI; post compared 
with pre) was calculated. Mean composite scores were 
modelled using linear mixed modelling; modelling was 
performed as above; however, the random intercept for 
service was always 0, and was removed from linear mixed 
modelling; crude mean scores for each time point and 
differences with 95% CI (post compared with pre) are 
presented. Model residuals were checked for heteroge-
neity and normality; empirical standard errors were calcu-
lated to account for any minor assumption violations.
Intraclass correlation coefficient (ICC) for HPs correla-
tion between time points, and between-service correla-
tion were calculated.
Sensitivity analysis of paired HPs responses
Sensitivity analysis of paired HPs responses was performed 
using responses from HPs who completed both presurveys 
and postsurveys; Wilcoxon signed-rank test was used to 
compare ordinal responses, and paired t-test to compare 
composite means between the two time points. 
 
Statistical analyses were programmed using SAS V.9.4. A 
priori, p<0.05 (two-tailed) was used to indicate statistical 
significance.
registration
The study was registered with the Australian and New 
Zealand Clinical Trials Registry.
Patient (hPs) involvement
The study was designed in collaboration with two AMSs, 
who also participated in the study.30 A working party 
that consisted of various HPs (and female community 
members) met with the researchers to collaboratively 
develop the educational resource package, which was 
also tested through focus groups of HPs from three other 
AMSs participating in the study.35 Each service employed 
one HPs (either an Aboriginal Health Worker or a 
midwife) to act as the research facilitator. They were in 
charge of recruiting HPs and conduct of the study. At the 
end of the study, members of the research team visited 
each service and discussed study results. An infographic 
showing study results was sent to all services.
results
Of 93 eligible HPs in the six services, 50 (54%) consented 
and filled out at least one survey—45 (90%) completed 
the pretraining survey and 20 (40%) completed the 
post-training survey. Fifteen (30%) HPs completed both 
surveys (table 1). Overall, 39 (42%) HPs participated 
in the webinar training. Figure 2 shows the breakdown 
of HPs for each service according to eligibility, training 
attendance and survey completion. HPs recruitment rate 
at the different AMSs ranged from 33% to 72%. All types 
of HPs were recruited, including 17 general practitioners, 
17 nurses/midwives, 10 Aboriginal Health Workers and 
six other (eg, social worker). One service (#6) did not 
provide any post-training surveys. Postsurveys were 
completed between 1 and 6 months postintervention 
(range 29–182 days, mean 97.5 days).
sCC knowledge
Total knowledge mean composite score improved signifi-
cantly from pre to post (77.9% vs 84% correct, difference 
5.95, 95% CI 1.57 to 10.32, ICC HPs 0.76). Breaking the 
total knowledge composite score into an NRT-specific 
and a non-NRT-specific mean composite scores shows a 
significant improvement for NRT-specific score but not 
for the non-NRT-specific score (78.8% vs 68.2% correct, 
difference 9.9, 95% CI 3.66 to 16.14, ICC HPs 0.71; 89.2% 
vs 87.7%, difference 1.89, 95% CI −3.46 to 7.24, ICC HPs 
0.52, respectively).
Attitudes to providing sCC
Table 2 provides crude responses and logistic modelling 
OR for all TDF domains. Seventy-five per cent of HPs 
reported ‘Strongly agreeing/Agreeing’ to having suffi-
cient resources postintervention compared with 36.4% 
preintervention (OR 5.70, 95% CI 1.44 to 22.58). Opti-
mism for effectiveness of their intervention with preg-
nant women who smoked showed a non-significant, 
but substantial effect size for improvement (60% post 
vs 31.8% pre, OR 3.3, 95% CI 0.95 to 11.51). Similarly, 
a non-significant, but substantial effect size was seen for 
reporting ‘Not often’ forgetting to provide counselling 
(75% post vs 59.1% pre, OR 2.21, 95% CI 0.55 to 8.87). 
Five out of the seven TDF domains NRT-specific questions 
also showed a non-significant, but substantial effect size 
(knowledge about how to counsel on NRT, confidence in 
ability to recommend/prescribe NRT, optimism that NRT 
will be effective, intention to prescribe NRT and less often 
forgetting to recommend/prescribe NRT (table 2)).
The total mean composite score for the general TDF 
domains improved significantly from 3.65 (SD 0.4) to 
3.87 (SD 0.4) (difference 0.23, 95% CI 0.05 to 0.41, ICC 
HPs 0.56). Mean composite NRT-specific TDF score was 
also significantly improved from 3.37 (0.6) to 3.64 (0.7) 
(difference 0.36, 95% CI 0.13 to 0.6, ICC HPs 0.74).
Table 3 presents the responses for self-reported percep-
tions on NRT safety, effectiveness and adherence, all 
showing a non-significant but substantial effect size for 
improvement.
Provision of sCC
Provision of SCC is shown in figure 3 and online supple-
mentary file 3. The odds of reporting on the provision 
of the different SCC components ‘Often/Always’ did 
not change significantly preintervention to postinterven-
tion, with the exception of ‘Recording smoking status’ in 
P
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the medical file, which was significantly reduced (96% 
vs 75% for pre and post, respectively, OR 0.14, 95% CI 
0.02 to 0.99). ‘Advise to quit smoking’, ‘Assess nicotine 
dependence’ and ‘Assist (provide cessation support)’ 
showed a non-significant, but substantial effect size for 
improvement. No change was observed for self-report on 
NRT prescribing rate (neither an increase in reporting 
‘Often/Always’ prescribing, nor a decrease in ‘Never’ 
prescribing).
The odds of reporting ‘Often/Always’ assessing the 
use of cannabis were unchanged pretraining to post-
training (OR 0.90, 95% CI 0.21 to 3.93). Assessing all 
other substances that expose the fetus to nicotine showed 
a non-significant, but substantial effect size for improve-
ment, including the use of electronic cigarettes with nico-
tine (OR 2.09, 95% CI 0.43 to 10.17), chewing tobacco 
(OR 2.67, 95% CI 0.55 to 13.01) and secondhand smoke 
(OR 2.51, 95% CI 0.68 to 9.31).
usefulness of educational resources (n=20, post-follow-up 
only)
All of the resources except the mouse pad were rated as 
useful with a mean ranging from 3.89 (SD 1.1) for the 
patient flipchart to 4.17 (SD 0.9) for the different types of 
NRT poster (median ‘useful (4)’ and mode ‘very useful 
(5)’ for all). The mouse pad was rated as somewhat useful, 
with a mean of 3.22 (SD 1.2) (both median and mode 
‘somewhat useful’). The webinar sessions were also rated 
as useful with a mean of 3.6 (SD 0.9), 3.8 (SD 1.0) and 3.9 
(SD 1.0) for session 1, 2, and 3, respectively (with both 
median and mode ‘useful’, except for session 3 (dedi-
cated to NRT), which had a mode of ‘very useful’). Eighty 
per cent (n=16) of participants reported reading at least 
part of the treatment manual, but only four reported 
reading all of the manual from front to back.
subanalysis of paired hPs responses
Similar results were seen for the paired analysis, except 
for assessment of other substance use that did not show 
any improvement in the paired analysis (online supple-
mentary file 4). As in the non-paired analysis, both mean 
knowledge composite score (post 5.8% higher than 
pre, 95% CI 1.32 to 10.35) and NRT-specific knowledge 
composite score (post 9.4% higher than pre, 95% CI 
2.72 to 16.17) improved significantly, and the total mean 
composite score for the general TDF domains improved 
significantly from 3.65 (SD 0.4) to 3.91 (SD 0.4) (difference 
0.26, 95% CI 0.04 to 0.47). Mean composite NRT-specific 
TDF score was also significantly improved from 3.4 (0.5) 
to 3.84 (0.5) (difference 0.44, 95% CI 0.2 to 0.67). Signif-
icant improvements were seen in self-reported attitudes 
including optimism, knowledge on NRT, perception that 
Table 1 Demographic characteristics of participants (n=50), n(%)
Characteristic Total n=50 Pre-training n=45 Post-training n=20
Age (mean, range), years 43.8 (18–64) 43.7 (18–64) 45.6 (29–64)
Gender—female 43 (86%) 39 (86.7%) 18 (90%)
Smoking status
  Current smoker (daily and occasional) 5 (10%) 5 (11.1%) 2 (10%)
  Ex-smoker 17 (34%) 13 (28.9%) 10 (50%)
  Never smoker 28 (56%) 27 (60%) 8 (40%)
Profession
  General practitioner 17 (34%) 15 (33.3%) 4 (20%)
  Midwife/nurse 16 (32%) 16 (35.6%) 6 (30%)
  Aboriginal Health Worker 10 (20%) 9 (20%) 5 (25%)
  Other* 7 (14%) 5 (11.1%) 5 (25%)
Work experience
  Less than 10 years 24 (48%) 20 (44.4%) 13 (65%)
  10–19 years 10 (20%) 10 (22.2%) 1 (5%)
  20 or more years 16 (32%) 15 (33.3%) 6 (30%)
Service
  1 4 (6%) (one matched) 3 (6.7%) 2 (10%)
  2 3 (6%) (three matched) 3 (6.7%) 3 (15%)
  3 13 (26%) (four matched) 11 (24.4%) 6 (30%)
  4 7 (14%) (three matched) 6 (13.3%) 4 (20%)
  5 13 (26%) (four matched) 12 (26.7%) 5 (25%)
  6 10 (20%) (0 matched) 10 (22.2%) 0 (0%)
*Other professions included all other allied health professionals, including family strengthening worker, social worker and psychologist.
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recommending/prescribing NRT is part of HPs work and 
intention to prescribe NRT. ‘Assessing’ nicotine depen-
dence also showed a significant improvement.
DIsCussIOn
Principal results
‘ICAN QUIT in Pregnancy’ was a pilot multicomponent 
intervention, including live interactive webinar training. 
Preliminary underpowered findings showed an improve-
ment in HPs knowledge and attitudes towards providing 
SCC in pregnancy. Furthermore, a non-significant, but 
substantial effect size was observed for improvement in 
several practices (‘Advise’, ‘Assess’ and ‘Assist’), and in 
assessment of overall exposures to tobacco and nicotine, 
including secondhand smoke and electronic cigarette 
use. NRT-specific knowledge and attitudes also improved, 
although no change was seen in self-reported NRT recom-
mendation/prescription rates.
limitations and strengths
This study was a pilot study not powered to test effec-
tiveness of changes in HPs knowledge, attitudes and 
practices. Our findings are suggestive that the interven-
tion might improve knowledge, attitudes and some prac-
tices. However, multiple comparisons were performed, 
which might indicate that not all findings are correct. Due 
to the small sample size, effect sizes should be interpreted 
cautiously. More conclusive results will require a larger 
trial. These results inform the design of SISTAQUIT, 
which will include 30 AMSs nationally in Australia, and 
will be powered to test intervention effectiveness, inclu-
sive of smoking cessation as an outcome for Aboriginal 
pregnant women. A major limitation of the current 
study was the low retention rates of the HPs, resulting 
in only 40% providing a post-training survey, and only 
one follow-up survey (instead of the planned two). The 
variability around when the postsurvey was completed is 
another limitation, as changes in knowledge, attitudes and 
practices may change over time. The low retention rates 
and small sample size limits our ability to interpret the 
findings, and to generalise them to all HPs and services, 
while raising the question of a selection bias. Assuming 
those who chose to answer the post-training survey might 
be the ones that benefited most from the intervention, 
Figure 2 Health providers’ eligibility, recruitment and retention per service. AHW, Aboriginal Health Worker; GP, general 
practitioner; OBS, Obstetrician.  
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actual changes in HP attributes may, in reality, be lower 
than results reported. Participating HPs might have been 
those who had more interest in smoking cessation; thus, 
representing better performing HPs. Despite this, to the 
best of our knowledge, this is the most extensive study 
to date undertaken within Australian AMSs evaluating 
smoking cessation during pregnancy. Inclusion of six 
services, from three different states, aids the potential 
generalisability of these findings.
Comparison with prior work
A recent systematic review identified 14 interventions 
on smoking cessation during pregnancy, which included 
data on HPs.28 This review found that interventions had a 
modest positive impact on the various SCC components. 
A few interventions also included data regarding knowl-
edge and attitudes of HPs,46–50 also showing an overall 
positive increase. None of the interventions included 
in this review were tailored to HPs treatment in indige-
nous populations, although a few were conducted with 
HP treating low socioeconomic populations.46 48 51–53 
Our results are similar and provide further evidence that 
interventions can modestly increase HPs knowledge, atti-
tudes and practices in supporting pregnant women to 
quit smoking, including in an Aboriginal context.
None of the interventions included in this system-
atic review incorporated any components specifically 
addressing NRT prescription, and/or knowledge and 
attitudes regarding NRT prescription, with only one 
measuring changes in NRT prescription rates preinterven-
tion and postintervention, with no differences observed.54 
Our intervention was designed specifically to address low 
NRT prescription rates, and is the first to include specific 
measures on knowledge, attitudes and practices of recom-
mending/prescribing NRT during pregnancy.
None of the previous interventions focusing on HPs 
care during pregnancy used webinar as the training 
delivery method.28 Lack of time, limited funding and lack 
of training are consistent barriers identified for health 
services and HPs to provide SCC during pregnancy.20 22 55 
Webinar is a novel approach and, if found to be effective in 
the SISTAQUIT trial, might provide an effective measure 
to conduct training and skill development, reducing both 
costs and time for travel. Thus, webinar training may 
be suitable specifically within rural and remote medical 
services. To the best of our knowledge, this study was the 
first to use this training mode for improving SCC during 
pregnancy.
Implication for policy and future research
As part of this intervention, oral NRT was supplied free 
within the service directly to the women throughout the 
study period. NRT patches were to be supplied as usual by 
providing women with a prescription, which they would 
fill at a pharmacy for a subsidised governmental rate. 
An analysis of actual provision of oral NRT31 throughout 
the study showed that 55% (12/22) of recruited women 
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at least occasionally. The data on NRT acceptance and 
usage might suggest that although HPs completing the 
postsurvey did not report changing NRT practices, their 
improved NRT-related knowledge and attitudes might 
have contributed to women’s perception and NRT accep-
tance levels. Computerised data from four services showed 
that government prescriptions for the NRT patch did not 
change across three services, and improved in one service 
(from one woman offered a prescription pretraining to 
four women post-training). Having the oral NRT within 
the service, supplied ‘on the spot’ free of charge, may 
have had an impact on both HPs and women’s practices, 
not reflected by the postsurvey of HPs. Reducing cost and 
logistic barriers may be helpful in improving the use of 
NRT in pregnancy.
Assessment of overall nicotine exposure of the fetus 
is important as nicotine in itself may be harmful, espe-
cially to the lung and brain development.56 57 Previous 
research has shown that over 75% of Australian HPs ask 
about tobacco use during pregnancy,22 58 yet the propor-
tion asking about exposure to other nicotine-containing 
products is limited (9%–38%).59 Raising awareness of 
these exposures by training is important with the emer-
gence of new nicotine-containing products, such as elec-
tronic cigarettes, and the uncertainties around the harm 
versus benefit of these alternate products in pregnancy. 
HPs should advise women that the best health benefits 
are seen with complete elimination of nicotine exposure 
in all forms. Future research needs to address whether, 
similar to NRT,16 17 electronic cigarettes can offer a ‘harm 
reduction’ strategy for pregnant women as well.
We were unable to provide the audit and feedback 
component at a service level as planned.31 Audit and feed-
back have been found to be an important component 
in interventions aimed at changing HPs behaviour in 
general.60 Future interventions should find ways to incor-
porate this as a feasible and acceptable method.
Changes to the future sIstAQuIt design
Results from this study have informed intervention 
development for the SISTAQUIT trial, including further 
incentives for HPs to participate (such as category one 
continuing professional development points and a 
prize-draw for survey completion). Surveys will be short-
ened, and training case study discussions will include 
videoed examples featuring the ABCD methods and how 
to conduct discussions about NRT with the pregnant 
woman. A full description of the recommended changes 
is described elsewhere.31
The ‘ICAN QUIT in Pregnancy’ pilot intervention was 
feasible with promising preliminary results. Strategies 
to increase HPs provision of NRT need to be improved, 
and the webinar training has been refined for the larger 
SISTAQUIT study. However, even a small increase in 
smoking cessation rates can have significant positive 
health impacts, both for the mother and baby, and help 
to close the health and life expectancy gap between the 
Aboriginal and non-Aboriginal Australian population.
COnClusIOns
Training HPs through live interactive webinar training 
and provision of educational resources was feasible, and 
might have a positive impact on HPs provision of SCC to 
pregnant Aboriginal women. Changes in NRT prescrip-
tion rates may require additional intensive measures. The 
AMSs have a significant role in the Aboriginal commu-
nity; therefore, improving capacity to support pregnant 
Aboriginal women to quit is vital and should be part of 
a comprehensive approach to tackle Aboriginal smoking 
rates during pregnancy. Using webinar training may have 
the potential to save both time and funds; thus, suitable 
especially for rural and remote medical services.
Author affiliations
1School of Medicine and Public Health, University of Newcastle, Callaghan, New 
South Wales, Australia
2Wollotuka Institute, University of Newcastle, Callaghan, New South Wales, Australia
3Clinical Research Design, Information Technology and Statistical Support 
(CReDITSS) Unit, Hunter Medical Research Institute, Newcastle, New South Wales, 
Australia
4UCL Centre for Behaviour Change, University College London, London, UK
Figure 3 Proportion of health providers self-reporting provision of SCC components ‘Often/Always’ vs else (and for NRT 
prescription ‘Never’ vs else). NRT, nicotine replacement therapy; SCC, smoking cessation care.
P
rotected by copyright.





























pen: first published as 10.1136/bm




12 Bar-Zeev Y, et al. BMJ Open 2019;9:e025293. doi:10.1136/bmjopen-2018-025293
Open access 
5School of Medicine, Western Sydney University, Penrith South DC, New South 
Wales, Australia
Acknowledgements The authors thank the Aboriginal communities who 
have contributed to the development and implementation of the ‘ICAN QUIT in 
Pregnancy’ intervention. This includes staff and patients of the Biripi Aboriginal 
Corporation, the Tobwabba Aboriginal Medical Service, the Pangula Mannamurna 
Aboriginal Corporation, the Riverina Medical and Dental Aboriginal Corporation, 
the Wuchopperen Health Service Ltd and the Tharawal Aboriginal Corporation. 
The authors also thank the members of the Stakeholder and Consumer Aboriginal 
Advisory Panel for ‘ICAN QUIT in Pregnancy’ for the ongoing guidance and support 
in implementing the study. We would also like to acknowledge Lauren Pollack who 
worked as a research assistant throughout the study and was responsible for the 
everyday administration of running this study.
Collaborators The following collaborators are in the ‘ICAN QUIT in Pregnancy’ 
Pilot Group: GSG, BB, Peter O’Mara, Marilyn Clarke, Chris Oldmeadow, Alan Clough, 
Kristin Carson, JR, YBZ, MB, Katherine Boydell, Ling Li Lim, MG, Roger Smith, 
Yvonne Cadet-James, Renee Bittoun, Lou Atkin, Brett Cowling and Lisa Orcher. 
Contributors GSG, YBZ and MB conceived and designed the study. YBZ led the 
data collection and analysis plan, and wrote the manuscript. MB and MG advised 
on Aboriginal community consultations and adherence to ethical guidelines to 
research with Aboriginal communities. BB and JR advised on methodology and 
implementation of the research. KP performed the statistical analysis, and CO 
oversaw the analysis and advised on methodology. LA advised on the design and 
the analysis using the Theoretical Domains Framework and Behaviour Change 
Wheel. The ‘ICAN QUIT in Pregnancy’ Pilot Group advised on the research design 
and implementation. GSG oversaw the entire study. All co-authors critically 
reviewed and approved the final manuscript.
Funding This work was supported by the NSW Ministry of Health and the Hunter 
Cancer Research Alliance. YBZ is supported by the University of Newcastle 
and Hunter Cancer Research Alliance PhD Scholarship. MB is supported by the 
University of Newcastle and Australian Heart Foundation Indigenous Scholarship 
(#101555). GSG is supported by the National Health and Medical Research Council 
and the Cancer Institute New South Wales Early Career Research Fellowships 
(APP1092085 and 15ECF/I-52). 
Competing interests YBZ has received funds in the past (2012–2015) from 
the Novartis NCH, who used to distribute NRT in Israel. She has not received any 
funding from pharmaceutical companies in Australia. 
Patient consent for publication Not required.
ethics approval Approval for this study was granted by the University of 
Newcastle Human Research Ethics Committee (HREC) (REF #H-2015-0438), the 
Aboriginal Health & Medical Research Council (AH&MRC) HREC (REF #1140/15), the 
South Australia Aboriginal HREC (REF #04-16-652) and the Far North Queensland 
HREC (REF #16/QCH/34-1040).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional unpublished data are available.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Chamberlain C, O'Mara-Eves A, Porter J, et al. Psychosocial 
interventions for supporting women to stop smoking in pregnancy. 
Cochrane Database Syst Rev 2017;2:CD001055.
 2. Lange S, Probst C, Rehm J, et al. National, regional, and global 
prevalence of smoking during pregnancy in the general population: 
a systematic review and meta-analysis. Lancet Glob Health 
2018;6:e769–e776.
 3. Australian Institute of Health and Welfare. Australia’s mothers and 
babies 2015—in brief. Canberra 2017.
 4. Australian Institute of Health and Welfare. Australia’s welfare 2017: in 
brief. Canberra.
 5. Brady M. Historical and cultural roots of tobacco use among 
Aboriginal and Torres Strait Islander people. Aust N Z J Public Health 
2002;26:120–4.
 6. Australian bureau of statistics. National aboriginal and torres strait 
islander social survey, 2014-15.
 7. van der Sterren A, Greenhalgh EM, Knoche D, et al. 8.1 Aboriginal 
peoples and Torres Strait Islanders: social disadvantage, health and 
smoking—an overview. In Scollo, MM and Winstanley, MH [editors].
Tobacco in Australia: Facts and issues. Cancer Council Victoria. 2016 
http://www. tobaccoinaustralia. org. au/ chapter- 8- aptsi/ 8- 1- overview.
 8. Read P, Japaljarri E. The price of tobacco: the journey of the 
Warlmala to Wave Hill, 1928. Aboriginal History 1978;2:140–8.
 9. Al-Yaman F. The australian burden of disease study: impact and 
causes of illness and death in aboriginal and torres strait islander 
people, 2011. Public Health Res Pract 2017;27.
 10. Australia C. Department of the prime minister and cabinet: Closing 
the Gap Prime Minister’s Report, 2018.
 11. Gould GS, Munn J, Watters T, et al. Knowledge and views about 
maternal tobacco smoking and barriers for cessation in Aboriginal 
and Torres Strait Islanders: A systematic review and meta-
ethnography. Nicotine Tob Res 2013;15:863–74.
 12. Gould GS, Munn J, Avuri S, et al. "Nobody smokes in the house 
if there's a new baby in it": Aboriginal perspectives on tobacco 
smoking in pregnancy and in the household in regional NSW 
Australia. Women Birth 2013;26:246–53.
 13. Bovill M, Gruppetta M, Cadet-James Y, et al. Wula (Voices) of 
Aboriginal women on barriers to accepting smoking cessation 
support during pregnancy: Findings from a qualitative study. Women 
Birth 2018;31:10–16.
 14. Twyman L, Bonevski B, Paul C, et al. Perceived barriers to smoking 
cessation in selected vulnerable groups: a systematic review of the 
qualitative and quantitative literature. BMJ Open 2014;4:e006414.
 15. Gould GS, Watt K, McEwen A, et al. Predictors of intentions to 
quit smoking in Aboriginal tobacco smokers of reproductive 
age in regional New South Wales (NSW), Australia: quantitative 
and qualitative findings of a cross-sectional survey. BMJ Open 
2015;5:e007020.
 16. Coleman T, Chamberlain C, Davey MA, et al. Pharmacological 
interventions for promoting smoking cessation during pregnancy. 
Cochrane Database Syst Rev 2015;12:CD010078.
 17. Bar-Zeev Y, Lim Ling L, Gruppeta M, et al. Nicotine replacement 
therapy for smoking cessation in pregnancy – a narrative review. 
Medical Journal of Australia 2018;208.
 18. Bar-Zeev Y, Bonevski B, Gruppetta M, et al. Clinician factors 
associated with prescribing nicotine replacement therapy in 
pregnancy: A cross-sectional survey of Australian obstetricians and 
general practitioners. Aust N Z J Obstet Gynaecol 2018;58:366–70.
 19. Gould GS, Bar-Zeev Y, Twyman L, et al. Health Professionals 
Performing the “5As” for smoking cessation and prescribing 
nicotine replacement therapy during pregnancy: meta-analysis 
of a systematic review. 2017 Hunter Cancer Research Alliance 
Symposium “Translating research for impact”. Asia-Pacific Journal of 
Clinical Oncology 2017;13:16.
 20. Okoli CTC, Greaves L, Bottorff JL, et al. Health care providers' 
engagement in smoking cessation with pregnant smokers. J Obstet 
Gynecol Neonatal Nurs 2010;39:64–77.
 21. Baxter S, Everson-Hock E, Messina J, et al. Factors relating to the 
uptake of interventions for smoking cessation among pregnant 
women: a systematic review and qualitative synthesis. Nicotine Tob 
Res 2010;12:685–94.
 22. Zeev YB, Bonevski B, Twyman L, et al. Opportunities missed: 
a cross-sectional survey of the provision of smoking cessation 
care to pregnant women by australian general practitioners and 
obstetricians. Nicotine Tob Res 2017;19:636–41.
 23. Tzelepis F, Daly J, Dowe S, et al. Supporting aboriginal women to 
quit smoking: antenatal and postnatal care providers' confidence, 
attitudes, and practices. Nicotine Tob Res 2017;19:642–6.
 24. Eades SJ, Sanson-Fisher RW, Wenitong M, et al. An intensive 
smoking intervention for pregnant Aboriginal and Torres Strait 
Islander women: a randomised controlled trial. Med J Aust 
2012;197:42–6.
 25. Passey M, Stirling J. Evaluation of ‘Stop Smoking in its Tracks’: an 
intensive smoking cessation program for pregnant Aboriginal women 
incorporating contingency-based financial rewards. Public Health 
Res Pract 2018;28:e28011804.
 26. Hudmon KS, Hoch MA, Vitale FM, et al. Tobacco cessation education 
for pharmacists: Face-to-face presentations versus live webinars. J 
Am Pharm Assoc 2014;54:42–4.
 27. Sarna L, Bialous SA, Ong MK, et al. Increasing nursing referral 
to telephone quitlines for smoking cessation using a web-based 
program. Nurs Res 2012;61:433–40.
 28. Bar-Zeev Y, Bonevski B, Lim LL, et al. Improving health providers 
smoking cessation care in pregnancy: a systematic review and meta-
analysis. Addict Behav 2019;93:29–38.
P
rotected by copyright.





























pen: first published as 10.1136/bm




13Bar-Zeev Y, et al. BMJ Open 2019;9:e025293. doi:10.1136/bmjopen-2018-025293
Open access
 29. Bar-Zeev Y, Bonevski B, Bovill M, et al. The Indigenous Counselling 
and Nicotine (ICAN) QUIT in Pregnancy Pilot Study protocol: a 
feasibility step-wedge cluster randomised trial to improve health 
providers' management of smoking during pregnancy. BMJ Open 
2017;7:e016095.
 30. Bovill M, Bar-Zeev Y, Gruppetta M, et al. Collective and negotiated 
design for a clinical trial addressing smoking cessation supports for 
Aboriginal and Torres Strait Islander mothers in NSW, SA and Qld - 
developing a pilot study. Aust J Prim Health 2017;23:497–503.
 31. Gould GS, Bovill M, Pollock L, et al. Feasibility and acceptability 
of Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy 
multicomponent implementation intervention and study design for 
Australian Indigenous pregnant women: a pilot cluster randomised 
step-wedge trial. Addict Behav 2019;90:176–90.
 32. Australian Institute of Health and Welfare. Healthy futures—aboriginal 
community controlled health services: report card. Canberra, 2016.
 33. NSW Health. Workforce planning and development. Definition of an 
aboriginal health worker. Report #IB2018_018.
 34. Gould GS, Bar-Zeev Y, Bovill M, et al. Designing an implementation 
intervention with the Behaviour Change Wheel for health provider 
smoking cessation care for Australian Indigenous pregnant women. 
Implement Sci 2017;12:114.
 35. Bar-Zeev Y, Bovill M, Bonevski B, et al. Assessing and validating an 
educational resource package for health professionals to improve 
smoking cessation care in aboriginal and torres strait islander 
pregnant women. Int J Environ Res Public Health 2017;14:1148.
 36. Dempsey D, Jacob P, Benowitz NL. Accelerated metabolism of 
nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 
2002;301:594–8.
 37. The Australian Goverment Depertment of Health. The pharmacutical 
benefits scheme: listings on the PBS for Aboriginal and torres strait 
islander people. http://www. pbs. gov. au/ info/ publication/ factsheets/ 
shared/ pbs- listings- for- aboriginal- and- torres- strait- islander- people.
 38. Gould GS, Bittoun R, Clarke MJ. A pragmatic guide for smoking 
cessation counselling and the initiation of nicotine replacement 
therapy for pregnant aboriginal and torres strait islander smokers. J 
Smok Cessat 2015;10:96–105.
 39. Gould GS, Bovill M, Clarke MJ, et al. Chronological narratives from 
smoking initiation through to pregnancy of Indigenous Australian 
women: A qualitative study. Midwifery 2017;52:27–33.
 40. Gould GS. Exploring the barriers and enablers to smoking cessation 
in pregnant Aboriginal and Torres Strait Islander women. Austral 
Epidemiol 2014;21:31–5.
 41. Gould GS, Watt K, Stevenson L, et al. Developing anti-tobacco 
messages for Australian Aboriginal and Torres Strait Islander 
peoples: evidence from a national cross-sectional survey. BMC 
Public Health 2014;14:250.
 42. Gould GS, Clarke MJ, Cadet-James Y, et al. “Our smoking and 
smoke-free stories” by Aboriginal women: a qualitative study. Perth, 
WA: GP16 Conference, 2016.
 43. Michie S, van Stralen MM, West R. The behaviour change wheel: 
a new method for characterising and designing behaviour change 
interventions. Implement Sci 2011;6:1–12.
 44. French SD, Green SE, O'Connor DA, et al. Developing theory-
informed behaviour change interventions to implement evidence 
into practice: a systematic approach using the Theoretical Domains 
Framework. Implement Sci 2012;7:38.
 45. Cane J, O'Connor D, Michie S. Validation of the theoretical domains 
framework for use in behaviour change and implementation research. 
Implement Sci 2012;7:37.
 46. Althabe F, Alemán A, Berrueta M, et al. A multifaceted strategy to 
implement brief smoking cessation counseling during antenatal care 
in argentina and uruguay: a cluster randomized trial. Nicotine Tob 
Res 2016;18:1083–92.
 47. Albrecht S, Kelly-Thomas K, Osborne JW, et al. The SUCCESS 
program for smoking cessation for pregnant women. J Obstet 
Gynecol Neonatal Nurs 2011;40:520–31.
 48. Velasquez MM, Hecht J, Quinn VP, et al. Application of motivational 
interviewing to prenatal smoking cessation: training and 
implementation issues. Tob Control 2000;9(Suppl 3):36iii–40.
 49. Valanis B, Labuhn KT, Stevens NH, et al. Integrating prenatal-
postnatal smoking interventions into usual care in a health 
maintenance organization. Health Promot Pract 2003;4:236–48.
 50. Naylor PJ, Adams JS, McNeil D. Facilitating changes in perinatal 
smoking. The impact of a stage-based workshop for care-providers 
in British Columbia. Can J Public Health 2002;93:285–90.
 51. Yusem SH, Rosenberg KD, Dixon-Gray L, et al. Public health nursing 
acceptance of the 5 A's protocol for prenatal smoking cessation. 
Californian Journal of Health Promotion 2004;2:1–10.
 52. Secker-Walker RH, Solomon LJ, Flynn BS, et al. Training obstetric 
and family practice residents to give smoking cessation advice 
during prenatal care. Am J Obstet Gynecol 1992;166:1356–63.
 53. Moss DR, Cluss PA, Watt-Morse M, et al. Targeting pregnant 
and parental smokers: long-term outcomes of a practice-based 
intervention. Nicotine Tob Res 2009;11:278–85.
 54. Chertok IR, Casey ML, Greenfield K. Approach to addressing 
prenatal smoking in West Virginia. W V Med J 2014;110:36–40.
 55. McFarlane KA, Judd J, Wapau H, et al. How primary health care 
staff working in rural and remote areas access skill development and 
expertise to support health promotion practice. Rural Remote Health 
2018;18:4413.
 56. England LJ, Aagaard K, Bloch M, et al. Developmental toxicity of 
nicotine: a transdisciplinary synthesis and implications for emerging 
tobacco products. Neurosci Biobehav Rev 2017;72:176–89.
 57. Smith AM, Dwoskin LP, Pauly JR. Early exposure to nicotine 
during critical periods of brain development: Mechanisms and 
consequences. J Pediatr Biochem 2010;1:125–41.
 58. Passey ME, D'Este CA, Sanson-Fisher RW. Knowledge, attitudes 
and other factors associated with assessment of tobacco smoking 
among pregnant Aboriginal women by health care providers: a cross-
sectional survey. BMC Public Health 2012;12:165.
 59. Gould GS, Zeev YB, Tywman L, et al. Do clinicians ask pregnant 
women about exposures to tobacco and cannabis smoking, 
second-hand-smoke and E-cigarettes? An Australian National 
Cross-Sectional Survey. Int J Environ Res Public Health 
2017;14:1585.
 60. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on 

































pen: first published as 10.1136/bm
jopen-2018-025293 on 4 June 2019. D
ow
nloaded from
 
